HIV stigma is a barrier to achieving the goals of the US Ending the HIV Epidemic initiative. We analyzed data from the Medical Monitoring Project (MMP) collected during 6/2018–5/2019 from 4050 US adults with diagnosed HIV. We reported national estimates of HIV stigma and assessed their associations with sociodemographic and clinical characteristics. Disclosure concerns and stigma related to negative public attitudes were common. Stigma was higher among younger age groups, women and transgender people, Black and Hispanic/Latino men and women, and Black and Hispanic/Latino men who have sex with men. Stigma was associated with lower antiretroviral therapy use and adherence, missed HIV care visits, and symptoms of depression or anxiety. The estimates presented provide a benchmark from which the nation can monitor its progress. The findings suggest the need for enhanced stigma-reduction efforts among specific groups and the importance of addressing stigma around disclosure and community attitudes.

艾滋病毒耻辱是实现美国终结艾滋病毒流行倡议目标的障碍。我们分析了医疗监测项目 (MMP) 于 2018 年 6 月至 2019 年 5 月期间从 4050 名被诊断为艾滋病毒的美国成年人收集的数据。我们报告了全国对艾滋病毒耻辱的估计，并评估了它们与社会人口和临床特征的关联。与负面公众态度相关的信息披露问题和耻辱很常见。在年轻群体、女性和跨性别者、黑人和西班牙裔/拉丁裔男性和女性、以及与男性发生性关系的黑人和西班牙裔/拉丁裔男性中，耻辱感更高。耻辱感与较低的抗逆转录病毒治疗使用率和依从性、错过艾滋病毒护理就诊以及抑郁或焦虑症状有关。所提出的估计提供了一个基准，国家可以据此监测其进展情况。研究结果表明，需要在特定群体中加强减少污名化的努力，以及解决围绕信息披露和社区态度的污名化问题的重要性。